Wegener granulomatosis causing sellar mass, hydrocephalus, and global pituitary failure.
Bertken
R D
RD
Department of Rheumatology, University Medical Center of Fresno, University of California, San Francisco 93703, USA.
Cooper
V R
VR
D000328:Adult; D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D003622:Dapsone / Q000627:therapeutic use; D003937:Diagnosis, Differential; D005260:Female; D005493:Folic Acid Antagonists / Q000627:therapeutic use; D014890:Granulomatosis with Polyangiitis / Q000150:complications* / Q000628:therapy; D006801:Humans; D006849:Hydrocephalus / Q000209:etiology* / Q000601:surgery; D009361:Neoplasm Invasiveness; D010911:Pituitary Neoplasms / Q000150:complications* / Q000473:pathology; D012658:Sella Turcica / Q000473:pathology
D018906:Antineoplastic Agents, Alkylating; D005493:Folic Acid Antagonists; D003520:Cyclophosphamide; D003622:Dapsone